Colorectal Cancer Screening (Septin9)
Type
Blood Testing
Biomarkers
1
Duration
20 min
Results
14 days
Blood-based early detection test for colorectal cancer via Septin9 gene methylation.
Multi-cancer screening uses blood-based biomarkers to screen for signs of multiple cancer types in a single test. These panels may include traditional tumor markers (PSA, CEA, CA-125, AFP), advanced liquid biopsy technology (circulating tumor DNA), or multi-analyte algorithms. The field of cancer early detection through blood testing is advancing rapidly, with new tests able to detect signals from dozens of cancer types — many of which have no standard screening method. While no blood test can definitively diagnose cancer on its own, abnormal results guide further investigation with imaging and biopsy. Early detection significantly improves treatment outcomes across nearly all cancer types.
Key Details
- Cancers Screened
- Multiple types (varies by panel)
- Fasting Required
- No (for most panels)
- Sample Type
- Blood draw
- Turnaround
- 1–3 weeks
- Important
- Screening tool — further evaluation needed for positive results
Who Is This For?
Health-conscious individuals seeking proactive cancer screening. People over 50 or those with a family history of multiple cancer types. Anyone interested in the latest advances in cancer early detection technology. Those who want screening beyond what standard guidelines recommend.
What's Included
Preparation Required
Fasting for 10–12 hours before your appointment is recommended for accurate results (water is fine). Avoid alcohol for 24 hours and intense exercise for 12 hours before the blood draw. Morning appointments are ideal for consistent hormone and glucose readings. The blood draw typically takes 5–10 minutes.
- Category
- Diagnostic
- Sample Type
- Blood draw
- Duration
- 20 min
- Results
- 14 days